Integrated Quantitative Investments LLC bought a new position in shares of DXC Technology (NYSE:DXC - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 52,000 shares of the company's stock, valued at approximately $1,039,000.
A number of other large investors have also recently modified their holdings of the business. Cerity Partners LLC boosted its stake in DXC Technology by 109.7% in the third quarter. Cerity Partners LLC now owns 38,752 shares of the company's stock valued at $804,000 after buying an additional 20,269 shares in the last quarter. Benjamin Edwards Inc. acquired a new stake in shares of DXC Technology in the 3rd quarter valued at approximately $664,000. Point72 Asset Management L.P. bought a new stake in shares of DXC Technology during the 3rd quarter valued at approximately $1,438,000. RBF Capital LLC acquired a new position in DXC Technology during the 3rd quarter worth approximately $622,000. Finally, XTX Topco Ltd lifted its stake in DXC Technology by 294.7% in the 3rd quarter. XTX Topco Ltd now owns 53,686 shares of the company's stock valued at $1,114,000 after purchasing an additional 40,085 shares during the last quarter. Institutional investors and hedge funds own 96.20% of the company's stock.
DXC Technology Trading Down 2.6 %
Shares of DXC stock traded down $0.36 during trading hours on Wednesday, hitting $13.74. 802,675 shares of the company's stock traded hands, compared to its average volume of 1,757,965. The stock has a market cap of $2.49 billion, a PE ratio of -32.83, a price-to-earnings-growth ratio of 1.16 and a beta of 1.37. The stock's 50 day simple moving average is $18.50 and its 200 day simple moving average is $20.08. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.12. DXC Technology has a 12 month low of $13.46 and a 12 month high of $24.83.
DXC Technology (NYSE:DXC - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.23. DXC Technology had a positive return on equity of 20.70% and a negative net margin of 0.57%. On average, sell-side analysts anticipate that DXC Technology will post 3.35 EPS for the current year.
Analyst Upgrades and Downgrades
Separately, Morgan Stanley boosted their target price on shares of DXC Technology from $20.00 to $22.00 and gave the stock an "equal weight" rating in a research note on Friday, January 31st. One equities research analyst has rated the stock with a sell rating and six have assigned a hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $21.29.
Check Out Our Latest Analysis on DXC
DXC Technology Profile
(
Free Report)
DXC Technology Company, together with its subsidiaries, provides information technology services and solutions in the United States, the United Kingdom, rest of Europe, Australia, and internationally. It operates in two segments, Global Business Services (GBS) and Global Infrastructure Services (GIS).
Featured Stories

Before you consider DXC Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DXC Technology wasn't on the list.
While DXC Technology currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.